A phase II study of hydrocodone for cough in advanced cancer

Jade Homsi, Declan Walsh, Kristine A. Nelson, Nabeel Sarhill, Lisa Rybicki, Susan B. Legrand, Mellar P. Davis

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

Purpose:Cough is a common symptom in advanced cancer. The use of hydrocodone as an antitussive has not been studied previously in this setting. This study evaluates hydrocodone for cough in advanced cancer.Methods:The results presented are from a phase II study with dose titration.Setting:Palliative medicine program in a tertiary referral center.Patients:25 consecutive patients with cough from irreversible causes, on a stable opioid regimen for the prior 24 hours, and no previous or current use of hydrocodone for cough.Intervention:5 mg hydrocodone was administered twice daily. The dose was then titrated daily (maximum: 60 mg/24 h), if needed, unti a350 percent improvement of the frequency of cough was achieved and then maintained for three consecutive days.Measurements:Cough severity, frequency, complications, and hydrocodone side effects.Results:20 persons (10 women and 10 men) completed study evaluation. Median age was 63 years (range: 42-82). Nine patients had lung cancer and seven had lung or pleura metastases; 19 patients had at least 50 percent improvement of their cough frequency. The median best response was 70 percent improvement in the cough frequency (range: 50-90 percent). Median hydrocodone dose associated with the best response was 10 mg/day (range: 5-30 mg/day). Cough severity, frequency, associated symptoms and complications, and activities of daily living improved significantly. Side effects of hydrocodone (dry mouth, nausea, and drowsiness) were tolerable and rated as mild.Conclusions:Hydrocodone is effective and safe to treat cough in advanced cancer. A starting dose of 10 mg per day in divided doses seems effective. Dose escalation may be required. Most improved within one day.

Original languageEnglish (US)
Pages (from-to)49-56
Number of pages8
JournalAmerican Journal of Hospice and Palliative Medicine
Volume19
Issue number1
DOIs
StatePublished - Jan 2002

Keywords

  • hospice nursing
  • human becoming (theory of)
  • living-dying rhythms
  • nursing practice
  • palliative care

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'A phase II study of hydrocodone for cough in advanced cancer'. Together they form a unique fingerprint.

  • Cite this

    Homsi, J., Walsh, D., Nelson, K. A., Sarhill, N., Rybicki, L., Legrand, S. B., & Davis, M. P. (2002). A phase II study of hydrocodone for cough in advanced cancer. American Journal of Hospice and Palliative Medicine, 19(1), 49-56. https://doi.org/10.1177/104990910201900110